JAEN CBAM MERCK SHARP & DOHME DE ESPAÑA, S.A. AM 1229/2024
TED · 396337-2026Award noticeawardedNo deadline given
Buyer
NameServicio Andaluz de Salud. Hospital Universitario de Jaén
CountryES
Published2026-06-10
Deadline—
Value
Estimated—
Awarded€1,762,142 · 1,762,141.71 EUR
WinnerMERCK SHARP & DOHNE DE ESPAÑA, S.A.
Who already wins at this buyer
Firms with recorded awards from Servicio Andaluz de Salud. Hospital Universitario de Jaén in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ASTRAZENECA FARMACEUTICA SPAIN, S.A. | 3 | €2,525,110 | 2026-06-25 |
| GLAXOSMITHKLINE, S.A. | 3 | €1,966,691 | 2026-06-10 |
| JANSSEN-CILAG, S.A. | 2 | €7,144,190 | 2026-06-10 |
| ROCHE FARMA, S.A. | 2 | €3,695,425 | 2026-06-10 |
| GILEAD SCIENCES, S.L. | 2 | €3,640,989 | 2026-06-10 |
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
CONTRATO BASADO EN EL CUERDO MARCO AM 1229/2024, MERCK SHARP & DOHME DE ESPAÑA, S.A. CBAM SUMINISTRO MEDICAMENTOS EXCLUSIVOS X (RELACIONADOS EN EL ANEXO I DEL PPT) PARA LOS CENTROS SANITARIOS QUE INTEGRAN LA CENTRAL PROVINCIAL DE COMPRAS DE JAÉN.
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-06-10 | JAEN CBAM MERCK, S.L. AM 1229/2024 | Servicio Andaluz de Salud. Hospital Universitario de Jaén ES | 97% |
| 2026-06-10 | JAEN CBAM AMGEN, S.A. AM 1229/2024 | Servicio Andaluz de Salud. Hospital Universitario de Jaén ES | 95% |
| 2026-06-10 | JAEN CBAM JANSSEN-CILAG, S.A. AM 1229/2024 | Servicio Andaluz de Salud. Hospital Universitario de Jaén ES | 95% |
| 2026-06-10 | JAEN CBAM ROCHE FARMA, S.A. AM 1229/2024 | Servicio Andaluz de Salud. Hospital Universitario de Jaén ES | 95% |
| 2026-06-10 | JAEN CBAM PFIZER, S.L. AM 1229/2024 | Servicio Andaluz de Salud. Hospital Universitario de Jaén ES | 95% |
| 2026-06-10 | JAEN CBAM TAKEDA FARMACEÚTICA ESPAÑA, S.A. AM 1229/2024 | Servicio Andaluz de Salud. Hospital Universitario de Jaén ES | 95% |